6 articles
Humana issues the first Medicare Advantage coverage policy for CVRx's Barostim baroreflex neuromodulation therapy effective 1 May 2026, the fourth 2026 reimbursement and trial milestone for the bioelectronic heart-failure category.
Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.
China's National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.
Two weeks after securing Breakthrough Device Designation for stroke rehabilitation, CorTec has been accepted into the FDA's TAP — a dedicated advisory track that pairs the German neurotech company with an agency liaison and early engagement with CMS, signalling an unusually long regulatory horizon for an implanted brain-computer interface.
Michel Maharbiz of iota Biosciences will keynote the ninth annual Bioelectronic Medicine Forum in New York on April 14, with panels on reimbursement and venture capital following a record Q1 for BCI funding.
A Health Affairs analysis argues that CMS needs a dedicated coverage pathway for implantable BCIs before the technology outpaces the reimbursement system that patients depend on.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.